Oil collectors are rarely used at present, but as a historical development process, it is the incubation period of combination drugs, and its practice and development provide inspiration for future combination drugs.
As a major breakthrough in the field of 1924 ~ 1926 flotation agents, soaps collector (1924), xanthate collector (1925) and dithio phosphate collector (1926) type plasma With the advent of collectors, the combined use of ionic collectors and hydrocarbon oils has increased, and the combined use of collectors has also begun to move from the spontaneous phase to the conscious phase. In the early 1930s, when soap was used to float apatite, the use of fuel oil as an additive reduced excessive foaming and increased flotation index. When xanthate flotation of lead and copper sulfide ore, adding a hydrocarbon oil may be strengthened and the metal ore flotation coarse ore gangue even the living body and, after the hydrocarbon oil collector in combination with an ionic increased, still the catch The combination of collection and use uses one aspect of research and application.
From the 1940s to the early 1950s, the combination of ionic collectors became the dominant aspect of the combined use of collectors. 1957 Stockholm International Conference on Mineral Processingæ ¼æž—åšèŒ¨åŸºreport presented a summary of catch in the use of a combination of collectors, when the US reported 29 lead zinc ore concentrator in seven processing plant, are used Combined collectors, 2 to 5 of the 22 copper selection plants use combined collectors. Combined collectors have also been applied to copper-selected plants in the former Soviet Union. The report also systematically introduced the test results of their use of different xanthate, combined flotation sulfide or yellow sulphate and sodium oleate combined flotation oxidized sulphide ore, and the isotope tracer method was used to determine the adsorption capacity of the agent. The relationship between recovery rates and the use of advanced electronic instruments to measure contact time to study the effect of combination drugs on the rate of adsorption. The presentation of this report has aroused widespread interest in the use of collector combinations and has facilitated the development of combination drug research and applications.
In the past 30 years, the combination of pharmaceuticals has entered a stage of vigorous development and has the following characteristics:
(1) The combination of flotation agents is used more and more widely, from the combination of collectors to the combination of inhibitors, the combination of foaming agents, the combination of flocculants, and the combination of collectors and The application is the most, followed by the inhibitor. The combination system has also evolved from a binary combination system to a multi-component system, and the type of the pharmaceutical combination has also been developed from the combination of the same type of similar agents to the combination of the use of the heterogeneous agents and the combination of the shaped agents.
According to the statistics of 59 non-ferrous metal selection plants in Northeast China Institute of Technology (now Northeastern University) in 1976, 33 collectors were used alone, and 26 were used in combination, accounting for 44% of the total number of selected plants.
In 1978, the British Mining Journal reported statistics on dozens of copper sulphide and copper and molybdenum plants. The plant used in the combination of foaming agents accounted for 26% in 1960 and 41% in 1975.
According to the survey of the fifth annual mineral processing pharmacy evaluation report of China, a total of 81 combinations of combination agents in 1986 and 1987, of which 58 were collectors, accounting for 72%; 19 were inhibitors, accounting for 23%; Three combinations of agents, accounting for 4%; one flocculant combination. Among the 81 combinations, the binary combination is 73%, 90%, and the ternary combination is 8%, of which 4 are collectors and inhibitors. In the collector combination, most of them are In addition to the combination of anionic and anionic combinations of the same type of collector, the number of anionic and nonionic, anionic and nonpolar, and anionic and cationic isoforms is nearly 10%.
(2) The proportion of patents for combined pharmaceuticals is quite large. Among the 81 combinations mentioned above, there are 27 patents, accounting for 33%. Among the 58 collector combinations, 23 are patents, accounting for about 40%. The author of this book counts the literature on flotation reagents of the former Soviet Union Mining Digests from 1977 to 1984, in which the patent volume accounts for about 42%, that is, the patent weight of the collector combination is close to the patent weight of the entire flotation agent research.
(3) The combination drug product appears, that is, the manufacturer combines certain drugs into a mixture product in a certain proportion, for example, the Aerofloat 208 agent is a combination of ethyl sodium black drug and sec-butyl sodium black drug in a 1:1 combination. The drug, Ucon290 agent is a mixture of 75% MIBC and 25% Erophorus-65.
Based on the above aspects, there are many combinations of drugs, which are difficult to enumerate one by one, and can only be classified as examples.
The combination of collectors is the most used type of flotation agent, and the statistics of Table 1, Table 2, and Table 3 fully demonstrate the wide range and combination of them. Table 4, Table 5, Table 6 and the following figure are combined collector flotation non-ferrous metal sulfide ore (copper ore), rare metal ore (tungsten ore), industrial mineral (phosphorus ore) and non-metallic ore (hornblende) Illustrative results. Among them, when flotation hornblende is octadecylamine as the main collector, other agents such as distilled tar oil (M II TM), oleic acid, sodium oleate, sodium salicylate, butanol, octanol, etc. Both are added as organic additives and can be considered as another type of combination. [next]
Mixed system | Mixed combination type | symbol | Example | |
Binary combination system | different type group Combined body system | Anionic + cationic Anionic + nonionic Anionic + non-polar Cationic + nonionic Cationic + non-polar Non-ionic + non-polar | AiCi AiNi AiNp CiNi CiNp NiNp | Ammonia combined with advanced xanthate flotation zinc oxide ore Yellow or black medicine combined with Z-200 flotation copper sulfide ore Combination of xanthate and hydrocarbon oil flotation copper molybdenum ore Amine and hydrocarbon oil combination flotation potassium salt Combination of xanthate and hydrocarbon oil flotation copper molybdenum ore |
Homotype heterogeneous combination system | Anionic + anionic Cationic + cationic Non-ionic + non-ionic Non-polar + non-polar | AiAi' CiCi' NiNi' NpNp' | Yellow medicine and black medicine combination flotation gold-bearing sulfide Fatty amine combined with ether amine flotation silicate Flotation of copper sulfide with ethyl xanthate ethyl formate and Z-200 Petroleum , shale oil, diesel combination flotation stibnite | |
Homomorphic combination system | Anionic + anionic Cationic + cationic Non-ionic + non-ionic Non-polar + non-polar | AiAi CiCi NiNi NpNp | Tall oil soap and paraffin oxide iron ore flotation compositions Flotation quartz with high boiling point fatty amine and low boiling point fatty amine Float copper ore with different viscosity of similar hydrocarbon oil | |
Multivariate combination system | Ternary heterogeneous combination system Ternary homogeneous combination system Ternary heterogeneous and homotypic combination system | AiCiNp AiAiAi AiAiAi | Primary amines with a fatty acid composition of oil and coal flotation of nickel Yellow medicine combined with black medicine and HM-50 flotation nickel ore Yellow medicine combined with black medicine and Z-200 flotation copper sulfide ore |
category | Pharmacy combination | Instance |
Similar combination | Xanthate + xanthate Black medicine + black medicine Mercaptans + mercaptans Alkyl sulfonates + alkyl sulfonates Carboxylic acid + carboxylic acid Hydroxamic acid + hydroxamic acid Organic tanic acid + organic tannin Organic phosphonic acid + organic phosphonic acid | Flotation of copper sulfide with butyl xanthate and isobutyl xanthate Black # 25 drugs and drug combinations aniline black lead sulfide flotation Flotation gold ore combined with dodecyl mercaptan and imidazole mercaptan Flotation iron ore with water-soluble petroleum sulfonic acid and oil-soluble petroleum sulfonic acid Flotation zircon in combination with sodium oleate and stearic acid C 7-9 hydroxamic acid and hydroxamic acid tall oil composition cassiterite flotation Flotation cassiterite combined with p-toluic acid and o-toluene decanoic acid Phosphate and Phosphate Combination Flotation Separation of Phosphate Ore and Carbonate Ore |
Heterogeneous combination | Xanthate + black medicine Xanthate + thiol Xanthate + carboxylic acid Xanthate + alkyl sulfonate Xanthate + Hydroxamic acid Xanthate + organic tannin Xanthate + organic phosphonic acid Carboxylic acid + hydroxyalkyl sulfonate Carboxylic acid + hydroxamic acid Carboxylic acid + organic tannin Carboxylic acid + organic phosphonic acid Carboxylic acid + black medicine Carboxylic acid + mercaptan | Flotation copper-nickel ore combined with butyl xanthate and butyl black drug Combination of xanthate and dodecyl mercaptan flotation copper-nickel ore Flotation of copper oxide with butyl xanthate and lower fatty acid Flotation of copper sulfide with butyl xanthate and sodium alkylbenzene sulfonate Xanthate and /HM-50 combined flotation copper oxide Flotation tungsten ore with xanthate and benzyl phthalic acid Oleic acid and alkyl sulfonate combined flotation lead oxide ore Flotation of andalusite in combination with sodium oleate and hydroxamic acid Benzyl phthalic acid% oxidized paraffin soap flotation cassiterite Flotation of cassiterite with 1-hydroxy-octyl-1,1-bisphosphonic acid and fatty acid Flotation of copper oxide ore with butyl ammonium black drug and oxidized paraffin soap |
Heterogeneous combination | Black medicine + thiol Black medicine + alkyl sulfonate Black medicine + hydroxamic acid Black medicine + organic tannins Black medicine + organic phosphonic acid Thiols + alkyl sulfonates Mercaptans + organic tannins Mercaptans + organic phosphonic acids Thiols + hydroxamic acids | Combination of black medicine and mercaptobenzothiazole flotation copper, lead and zinc ore Fluorinated oxidizing agent combined with butyl ammonium black drug and C 7 - 9 hydroxamic acid |
Alkyl sulfonates + hydroxamic acids | Combination of hydroxamic acid with alkyl sulfonate (and non-polar oil) flotation phosphate rock | |
Alkyl sulfonates + organic phthalic acids Alkyl sulfonates + organic phosphonic acids | Flotation cassiterite combined with toluene acid (with kerosene) and alkyl sulfonate | |
Hydroxamic acid + organic tannic acid Hydroxamic acid + organic phosphonic acid | ||
Organic tanic acid + organic phosphonic acid | Flotation cassiterite in combination with p-toluic acid and p-ethylbenzenephosphonic acid |
Combination agent | Number of instances /a | Distribution rate /% |
Sulfide ore collector combination | 190 | |
Xanthate + xanthate Black medicine + black medicine Xanthate + black medicine Xanthate + ionic sulfhydryl Black medicine + ionic sulfhydryl Xanthate + sulfur-containing non-ionic (polar) type Black medicine + sulfur-containing non-ionic (polar) type Sulfur-containing nonionic (polar) type + sulfur-containing nonionic (polar) type Mercaptans + mercaptans, mercaptans, thirteen thiocarbonates or xanthates Xanthate + hydrocarbon Black medicine + hydrocarbon Xanthate + fatty acids Xanthate + alkyl sulfonic acid Xanthate (+ black medicine) + hydroxamic acid Other: sulfur-containing nonionic polar type + hydrocarbon or mercaptan Fatty acid + amine or sulfonate, thiol + phenol oil, etc. | 39 4 37 12 2 38 6 3 4 twenty four 3 4 3 5 6 | 20.5 2.1 19.5 6.3 1.1 20.0 3.2 1.6 2.1 12.6 1.6 2.1 1.6 2.6 3.2 |
Non-ferrous metal oxide ore collector combination | 53 | |
Xanthate (+ black medicine) + chelation reagent Xanthate (+ black medicine) + hydroxamic acid Chelating Reagents + Hydrocarbons Hydroxamic acid + hydrocarbons, xanthate + hydrocarbons (or added fatty acids) Xanthate + fatty acids Xanthate + black medicine (or thiol) | 9 11 7 3 6 6 | 17.0 20.8 13.2 5.7 11.3 11.3 |
Non-ferrous metal oxide ore collector combination | 53 | |
Hydroxamic acid + fatty acid (or plus xanthate) Xanthate + amine Amine + amine, amine + fatty acid Other: chelating agent + chelating agent, oleic acid + petroleum sulfonic acid, etc. | 2 3 2 4 | 3.8 5.7 3.8 7.5 |
Rare metal ore collector combination | 47 | |
Fatty acids + fatty acids Fatty acids + amines Fatty acids + hydrocarbons Fatty acids + organic phosphates Fatty acids + organic tannins Hydroxamic acid + chelating reagent Organic tanic acid + hydrocarbon Hydroxamic acid + hydrocarbon Organic decanoic acid + organic citric acid, organic phosphonic acid + organic phosphonic acid Organic decanoic acid + organic phosphonic acid Other: organic phosphonic acid + xanthate (thiourea), etc. | 12 6 7 4 5 2 2 2 3 4 | 25.5 12.8 14.9 8.5 10.6 4.3 4.3 4.3 6.4 8.5 |
Ferrous metal ore and non-metallic mineral collector combination | 148 | |
Fatty acids + fatty acids Fatty acid + (sulfonated, sulfated, halogenated) fatty acids Fatty acid (+ fatty acid) + adjuvant Fatty acid (+ fatty acid) + hydrocarbon Fatty acid + amine Fatty acid + hydroxamic acid Alkyl sulfonate + alkyl sulfonate Alkyl sulfonate + hydrocarbon (or additive) Fatty acid + organic phosphonic acid Amines + amines (hydrocarbons) Hydrocarbons + hydrocarbons Other: Hydroxamic acid + alkyl sulfonate (+ hydrocarbon), organophosphine Acid + organic phosphonic acid, alkyl sulfuric acid + alkyl sulfuric acid, etc. | 35 15 26 20 4 4 5 9 3 15 4 8 | 23.6 10.1 17.6 13.5 2.7 2.7 3.4 6.1 2.0 10.1 2.7 5.4 |
Pharmacy | Pharmacy cost /yuan·t -1 | Raw ore grade /% | Copper concentrate grade /% | Recovery rate /% | |||
copper | Zinc | copper | Zinc | copper | Zinc | ||
Butyl xanthate Nylonine black medicine Butyl xanthate + butyl ammonium black medicine (2:1) Butyl xanthate + butyl ammonium black medicine (1:1) | 13.7 9.58 8.90 8.25 | 0.76 0.75 0.77 0.74 | 1.16 1.06 1.14 1.02 | 14.31 14.51 18.46 20.21 | 3.45 2.96 2.16 2.34 | 88.71 90.86 91.67 92.43 | 14.98 13.54 14.17 13.74 |
Collector name | Collector dosage / kg·t -1 | Concentrate /% | Tailings grade /% | Raw ore grade /% | Sorting indicator /% | ||
Yield | grade | Recovery rate | |||||
Benzyl phthalic acid Mixed toluene Styrene phosphonic acid | 0.2 | 11.34 10.02 8.87 | 30.30 33.99 37.65 | 97.49 95.71 95.56 | 0.10 0.17 0.17 | 3.520 3.595 3.494 | 86.15 85.69 86.69 |
Benzyl phthalic acid Mixed toluene Styrene phosphonic acid | 0.15 | 10.61 10.06 9.29 | 32.37 33.24 36.60 | 96.24 94.41 94.19 | 0.15 0.22 0.21 | 3.57 3.54 3.26 | 85.63 84.35 84.88 |
Benzyl phthalic acid Mixed toluene Styrene phosphonic acid | 0.10 | 10.00 9.97 9.03 | 30.84 31.08 34.57 | 96.62 95.83 89.33 | 0.12 0.15 0.41 | 3.14 3.277 3.495 | 86.62 85.86 80.30 |
Benzyl phthalic acid | 8.87 | 30.21 | 89.96 | 0.33 | 3.000 | 81.09 |
Pharmacy type | Dosage /g·t -1 | Concentrate /%BPL | Concentrate insolubles/% | Tailings /%BPL | Tailings insolubles /% | Recovery rate /%BPL |
Tar oil fatty acid Tar oil fatty acid Ether sulfate (2:1) | 136 273 408 544 136 273 408 544 | 35.40 41.52 40.86 36.27 55.06 53.97 52.88 53.53 | 49.56 42.99 43.71 49.66 23.65 25.09 26.99 25.20 | 13.93 6.56 3.28 1.97 7.05 3.06 2.40 1.75 | 79.50 90.15 94.55 94.66 86.54 94.55 95.86 96.39 | 10.56 64.84 34.36 90.28 57.34 83.00 89.02 92.29 |
Figure 8-4-1 pH=6.5(1) and 9.5(2) and 6. 2(3) using octadecylamine as a collector,
Effect of the amount of fat (a), phenol and polyethylene (b) and ether alcohol (c) on the flotation of hornblende
Stainless Steel Cold Heading Wire
Stainless Steel Cold Heading Wire,Stainless Steel Bright Wire,Stainless Annealed Wire,Stainless Steel Soft Binding Wire
Jiangsu Manrui New Materials Co., Ltd , https://www.manruiweldingwire.com